Page 20 - hypertension_newsletter

REFLECTIONS
Hypertension
Hypertension Global Newsletter #10 2026

CONFERENCE CORNER Hypertension

The ESH Congress, hosted in Gdańsk, Poland, on May 28 – May 31 , 2026, is the annual meeting
st
th
of the European Society of Hypertension. We present below some abstracts of interest that may have
an impact on clinical practice. Please visit the conference website to explore the full program and daily
summary videos.

FRIDAY MAY 29 – CLINICAL TRIAL. HOT LINE SESSION 1
TH

1. Effect of the dual endothelin receptor antagonist aprocitentan on albuminuria. Schlaich M, et al.

FRIDAY MAY 29 – CLINICAL STUDIES
TH

2. Triple antihypertensive single-pill combinations included as a WHO essential medicine: Critical review of efficacy,
safety, cost, and policy implications. Satheesh G, et al.

3. Advanced cardiovascular-kidney-metabolic syndrome and combined macrovascular and microvascular events in
diabetes patients: Results from ADVANCE. You S, et al.

FRIDAY MAY 29 – BLOOD PRESSURE PHENOTYPES
TH
4. Association between short-term blood pressure variability and arterial stiffness in a prehypertensive population.
Liu M, et al.

5. Prevalence and cardio-kidney-metabolic profiles across AHA 2025 blood pressure categories in 32,046 adults with
type 2 diabetes in a high-risk population. Ahmed K, et al.

SATURDAY MAY 30 – REAL-WORLD EVIDENCE
TH

6. Bosphore study: Comparative effectiveness of triple therapy – bisoprolol, perindopril, amlodipine – versus dual
therapy in uncontrolled hypertensive patients: An observational cohort. Tsioufis K, et al.
7. Real-world analysis of adherence, persistence and outcomes in patients receiving quadruple therapy with
perindopril, indapamide, amlodipine and bisoprolol in Italy. Mancia G, et al.

SATURDAY MAY 30 – CLINICAL TRIALS. HOT LINE SESSION 2
TH

8. KARDIA-3: Zilebesiran as add-on therapy in adults with hypertension and established cardiovascular disease or
high cardiovascular risk with and without chronic kidney disease. Pagidipati N, et al.

SATURDAY MAY 30 – GLOBAL AND ENVIRONMENTAL DETERMINANTS OF
TH
BLOOD PRESSURE

9. Global perspectives on blood pressure and stroke risk: A systematic review comparing Asian and Western
populations. Tsoi K, et al.

10. Co-occurrence of cardiovascular-kidney-metabolic conditions in the May measurement month global campaign
2023. Kerr G, et al.

TABLE OF CONTENTS